ATE496046T1 - Arylvinylazacycloalkan-verbindungen und verfahren zu deren herstellung und verwendung - Google Patents

Arylvinylazacycloalkan-verbindungen und verfahren zu deren herstellung und verwendung

Info

Publication number: ATE496046T1
Authority: AT; Austria
Prior art keywords: arylvinylazacycloalkan; compounds; production; methods; arylvinylazacycloalkan compounds
Prior art date: 2003-03-05

Application number

AT09075124T

Other languages

English (en)

Inventor

Arielle Genevois-Borella

Craig Harrison Miller

Original Assignee

Targacept Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-03-05

Filing date

2004-03-04

Publication date

2011-02-15

2004-03-04 Application filed by Targacept Inc filed Critical Targacept Inc

2011-02-15 Application granted granted Critical

2011-02-15 Publication of ATE496046T1 publication Critical patent/ATE496046T1/de

Links

150000001875 compounds Chemical class 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Pain & Pain Management (AREA)
Psychiatry (AREA)
Addiction (AREA)
Epidemiology (AREA)
Psychology (AREA)
Virology (AREA)
Physical Education & Sports Medicine (AREA)
Immunology (AREA)
Orthopedic Medicine & Surgery (AREA)
Hospice & Palliative Care (AREA)
Anesthesiology (AREA)
Communicable Diseases (AREA)
Urology & Nephrology (AREA)
Molecular Biology (AREA)
Tropical Medicine & Parasitology (AREA)
Cardiology (AREA)
Oncology (AREA)
Rheumatology (AREA)
Vascular Medicine (AREA)
Heart & Thoracic Surgery (AREA)
AIDS & HIV (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

AT09075124T 2003-03-05 2004-03-04 Arylvinylazacycloalkan-verbindungen und verfahren zu deren herstellung und verwendung ATE496046T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US10/379,868 US7098331B2 (en)	2003-03-05	2003-03-05	Arylvinylazacycloalkane compounds and methods of preparation and use thereof

Publications (1)

Publication Number	Publication Date
ATE496046T1 true ATE496046T1 (de)	2011-02-15

Family

ID=32926772

Family Applications (3)

Application Number	Title	Priority Date	Filing Date
AT08075106T ATE517893T1 (de)	2003-03-05	2004-03-04	Arylvinylazacycloalkan-verbindungen sowie herstellungsverfahren dafür und verwendung davon
AT04717398T ATE394394T1 (de)	2003-03-05	2004-03-04	Arylvinylazacycloalkane verbindungen und methoden zu ihrer herstellung und deren verwendung
AT09075124T ATE496046T1 (de)	2003-03-05	2004-03-04	Arylvinylazacycloalkan-verbindungen und verfahren zu deren herstellung und verwendung

Family Applications Before (2)

Application Number	Title	Priority Date	Filing Date
AT08075106T ATE517893T1 (de)	2003-03-05	2004-03-04	Arylvinylazacycloalkan-verbindungen sowie herstellungsverfahren dafür und verwendung davon
AT04717398T ATE394394T1 (de)	2003-03-05	2004-03-04	Arylvinylazacycloalkane verbindungen und methoden zu ihrer herstellung und deren verwendung

Country Status (31)

Country	Link
US (8)	US7098331B2 (de)
EP (3)	EP2085395B1 (de)
JP (3)	JP4663627B2 (de)
KR (4)	KR101018083B1 (de)
CN (3)	CN101550132B (de)
AR (3)	AR043469A1 (de)
AT (3)	ATE517893T1 (de)
AU (3)	AU2004217903B2 (de)
BR (1)	BRPI0409576A (de)
CA (1)	CA2516514C (de)
CL (1)	CL2004000452A1 (de)
CY (2)	CY1110391T1 (de)
DE (2)	DE602004013553D1 (de)
DK (2)	DK1601670T3 (de)
EA (3)	EA019240B1 (de)
ES (3)	ES2389106T3 (de)
GT (1)	GT200400033A (de)
IL (3)	IL170155A (de)
JO (1)	JO2488B1 (de)
MX (1)	MXPA05009386A (de)
NO (3)	NO331920B1 (de)
NZ (1)	NZ541795A (de)
PA (1)	PA8597201A1 (de)
PE (1)	PE20040930A1 (de)
PL (5)	PL216979B1 (de)
PT (2)	PT2085395E (de)
SI (2)	SI2085395T1 (de)
TW (3)	TWI377204B (de)
UY (1)	UY28218A1 (de)
WO (1)	WO2004078752A1 (de)
ZA (1)	ZA200506790B (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7098331B2 (en) *	2003-03-05	2006-08-29	Targacept, Inc.	Arylvinylazacycloalkane compounds and methods of preparation and use thereof
FR2896800B1 (fr) *	2006-01-30	2008-04-11	Servier Lab	Nouveaux composes pyridinylaminoalkylene-et pyridinyloxyalkylene-cyclopropanamines polysubstitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
WO2008157365A2 (en) *	2007-06-15	2008-12-24	Targacept, Inc.	Vinylazacycloalkanes for treating neuropathic pain
EP2296640A1 (de) *	2008-05-12	2011-03-23	Targacept Inc.	Verfahren zur prävention der entwicklung von retinopathie durch orale verabreichung von nnr-liganden
TW201024283A (en)	2008-12-01	2010-07-01	Targacept Inc	Synthesis and novel salt forms of (R)-3-((E)-2-(pyrrolidin-3-yl)vinyl)-5-(tetrahydropyran-4-yloxy)pyridine
US9145396B2 (en)	2008-12-01	2015-09-29	Targacept, Inc.	Synthesis and novel salt forms of (R)-5-((E)-2-pyrrolidin-3ylvinyl)pyrimidine
IL266097B (en)	2008-12-01	2022-07-01	Oyster Point Pharma Inc	Mono-orotate acid addition salt of r(–5–)–e(–2–)pyrrolidine––3ylvinyl)pyrimidine
WO2010080757A2 (en)	2009-01-07	2010-07-15	Astrazeneca Ab	Combinations with an alpha-4beta-2 nicotinic agonist
RU2012101424A (ru) *	2009-06-17	2013-07-27	Таргасепт, Инк.	Устранение l-дофа-индуцированной дискинезии с помощью лигандов нейрональных никотиновых рецепторов
AU2010328419A1 (en)	2009-12-07	2012-06-21	Targacept, Inc.	3,6-diazabicyclo[3.1.1]heptanes as neuronal nicotinic acetylcholine receptor ligands
US20130237550A1 (en) *	2010-03-11	2013-09-12	Targacept, Inc.	Arylvinylazacycloalkane compounds for constipation
US20110274628A1 (en) *	2010-05-07	2011-11-10	Borschke August J	Nicotine-containing pharmaceutical compositions
US20140081714A1 (en) *	2012-09-19	2014-03-20	Salesforce.Com, Inc.	Systems and methods of rewarding users in an on-demand system
US20140278929A1 (en) *	2013-03-15	2014-09-18	Yahoo! Inc.	System and method identifying opportunities for advertising entities based on user goal achievement
NZ746468A (en) *	2016-04-07	2023-06-30	Oyster Point Pharma Inc	Methods of treating ocular conditions
KR101848601B1 (ko) *	2016-07-27	2018-04-12	송기봉	일회용 위생 티슈
EP3820443A1 (de)	2018-07-10	2021-05-19	Oyster Point Pharma, Inc.	Kombinationen von positiven allosterischen modulatoren und nikotinischen acetylcholinrezeptoragonisten zur behandlung von augenleiden
WO2020014217A1 (en)	2018-07-10	2020-01-16	Oyster Point Pharma, Inc.	Methods of treating ocular conditions
EP4142734B1 (de)	2020-04-28	2025-08-20	Oyster Point Pharma, Inc.	Lokale verabreichung von nikotinischen acetylcholinrezeptoragonisten zur hemmung von coronavirusinfektionen

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1989000158A1 (en)	1987-07-02	1989-01-12	Pfizer Inc.	Bridged-diazabicycloalkyl quinolone carboxylic acids and esters
US4922901A (en) *	1988-09-08	1990-05-08	R. J. Reynolds Tobacco Company	Drug delivery articles utilizing electrical energy
US5187166A (en) *	1990-07-31	1993-02-16	Nisshin Flour Milling Co., Ltd.	Azabicyclo derivatives and their use as antiemetics
IL107184A (en)	1992-10-09	1997-08-14	Abbott Lab	Heterocyclic ether compounds that enhance cognitive function
US5852041A (en) *	1993-04-07	1998-12-22	Sibia Neurosciences, Inc.	Substituted pyridines useful as modulators of acethylcholine receptors
IT1274018B (it) *	1994-02-23	1997-07-14	Riace Ets	Derivati del 3,8-diazabiciclo(3.2.1.)ottano ad attivita' analgesica
GB2295387A (en)	1994-11-23	1996-05-29	Glaxo Inc	Quinazoline antagonists of alpha 1c adrenergic receptors
US5604231A (en) *	1995-01-06	1997-02-18	Smith; Carr J.	Pharmaceutical compositions for prevention and treatment of ulcerative colitis
US5597919A (en) *	1995-01-06	1997-01-28	Dull; Gary M.	Pyrimidinyl or Pyridinyl alkenyl amine compounds
US5585388A (en)	1995-04-07	1996-12-17	Sibia Neurosciences, Inc.	Substituted pyridines useful as modulators of acetylcholine receptors
US5583140A (en) *	1995-05-17	1996-12-10	Bencherif; Merouane	Pharmaceutical compositions for the treatment of central nervous system disorders
IL118279A (en)	1995-06-07	2006-10-05	Abbott Lab	Compounds 3 - Pyridyloxy (or Thio) Alkyl Heterocyclic Pharmaceutical Compositions Containing Them and Their Uses for Preparing Drugs to Control Synaptic Chemical Transmission
US5616716A (en) *	1996-01-06	1997-04-01	Dull; Gary M.	(3-(5-ethoxypyridin)yl)-alkenyl 1 amine compounds
AT403803B (de)	1996-04-19	1998-05-25	Sanochemia Ltd	Neue benzazepinderivate, diese enthaltende arzneimittel und verwendung derselben zum herstellen von arzneimitteln
US5663356A (en) *	1996-04-23	1997-09-02	Ruecroft; Graham	Method for preparation of aryl substituted alefinic secondary amino compounds
US6437138B1 (en) *	1996-06-06	2002-08-20	Abbott Laboratories	3-pyridyloxymethyl heterocyclic ether compounds useful in controlling chemical synaptic transmission
US5629325A (en)	1996-06-06	1997-05-13	Abbott Laboratories	3-pyridyloxymethyl heterocyclic ether compounds useful in controlling chemical synaptic transmission
KR100607838B1 (ko)	1997-10-27	2006-08-04	뉴로서치 에이/에스	니코틴 작용성 아세틸콜린 수용체상의 콜린 작용성 리간드로서의 호모피페라진 유도체 및 이를 포함하는 약제학적 조성물
WO2000075110A1 (en)	1999-06-07	2000-12-14	Targacept, Inc.	Pharmaceutical compositions and methods for use
EP1212319A2 (de)	1999-09-14	2002-06-12	Abbott Laboratories	3-pyrrolidinyloxy-3' -pyridyl ether verbindungen verwendbar zur steuerung von chemischer synaptischer übertragung
JP2003513054A (ja)	1999-11-01	2003-04-08	ターガセプト，インコーポレイテッド	アリールオレフィンアザ環式化合物及びアリールアセチレンアザ環式化合物、それらを含有する薬剤組成物、及び、ニコチンコリン作動性受容体の阻害薬としてのそれらの使用
US6624167B1 (en) *	2000-08-04	2003-09-23	Targacept, Inc.	Pharmaceutical compositions and methods for use
AU2002322562A1 (en)	2001-07-19	2003-03-03	Medical College Of Georgia Research Institute	Novel analogs of choline for neuroprotection and cognitive enhancement in neurodegenerative disorders
US7098331B2 (en)	2003-03-05	2006-08-29	Targacept, Inc.	Arylvinylazacycloalkane compounds and methods of preparation and use thereof

2003
- 2003-03-05 US US10/379,868 patent/US7098331B2/en not_active Expired - Lifetime
2004
- 2004-02-10 TW TW098105931A patent/TWI377204B/zh not_active IP Right Cessation
- 2004-02-10 TW TW093103017A patent/TWI339662B/zh not_active IP Right Cessation
- 2004-02-10 TW TW098105932A patent/TW200927746A/zh unknown
- 2004-03-02 PE PE2004000228A patent/PE20040930A1/es not_active Application Discontinuation
- 2004-03-04 AU AU2004217903A patent/AU2004217903B2/en not_active Ceased
- 2004-03-04 EP EP09075124A patent/EP2085395B1/de not_active Expired - Lifetime
- 2004-03-04 KR KR1020097002098A patent/KR101018083B1/ko not_active Expired - Fee Related
- 2004-03-04 MX MXPA05009386A patent/MXPA05009386A/es active IP Right Grant
- 2004-03-04 CA CA2516514A patent/CA2516514C/en not_active Expired - Lifetime
- 2004-03-04 BR BRPI0409576-6A patent/BRPI0409576A/pt not_active IP Right Cessation
- 2004-03-04 PL PL378415A patent/PL216979B1/pl unknown
- 2004-03-04 EA EA200900706A patent/EA019240B1/ru not_active IP Right Cessation
- 2004-03-04 PA PA20048597201A patent/PA8597201A1/es unknown
- 2004-03-04 AR ARP040100690A patent/AR043469A1/es not_active Application Discontinuation
- 2004-03-04 DK DK04717398T patent/DK1601670T3/da active
- 2004-03-04 PL PL04717398T patent/PL1601670T3/pl unknown
- 2004-03-04 AT AT08075106T patent/ATE517893T1/de not_active IP Right Cessation
- 2004-03-04 SI SI200431638T patent/SI2085395T1/sl unknown
- 2004-03-04 PT PT09075124T patent/PT2085395E/pt unknown
- 2004-03-04 GT GT200400033A patent/GT200400033A/es unknown
- 2004-03-04 PL PL09075124T patent/PL2085395T3/pl unknown
- 2004-03-04 EP EP04717398A patent/EP1601670B1/de not_active Expired - Lifetime
- 2004-03-04 PL PL394600A patent/PL394600A1/pl unknown
- 2004-03-04 CN CN2009100048828A patent/CN101550132B/zh not_active Expired - Fee Related
- 2004-03-04 KR KR1020127001576A patent/KR20120014236A/ko not_active Ceased
- 2004-03-04 AT AT04717398T patent/ATE394394T1/de active
- 2004-03-04 CN CNB2004800060242A patent/CN100526308C/zh not_active Expired - Lifetime
- 2004-03-04 DE DE602004013553T patent/DE602004013553D1/de not_active Expired - Lifetime
- 2004-03-04 PL PL394604A patent/PL215059B1/pl unknown
- 2004-03-04 KR KR1020097002099A patent/KR100953150B1/ko not_active Expired - Fee Related
- 2004-03-04 SI SI200430775T patent/SI1601670T1/sl unknown
- 2004-03-04 KR KR1020057016343A patent/KR101185541B1/ko not_active Expired - Fee Related
- 2004-03-04 EP EP08075106A patent/EP1947100B1/de not_active Expired - Lifetime
- 2004-03-04 NZ NZ541795A patent/NZ541795A/en not_active IP Right Cessation
- 2004-03-04 CN CNA2008100917335A patent/CN101255155A/zh active Pending
- 2004-03-04 JP JP2006509059A patent/JP4663627B2/ja not_active Expired - Fee Related
- 2004-03-04 ES ES08075106T patent/ES2389106T3/es not_active Expired - Lifetime
- 2004-03-04 JO JO200422A patent/JO2488B1/en active
- 2004-03-04 EA EA200801764A patent/EA014714B1/ru not_active IP Right Cessation
- 2004-03-04 ES ES09075124T patent/ES2385941T3/es not_active Expired - Lifetime
- 2004-03-04 UY UY28218A patent/UY28218A1/es not_active Application Discontinuation
- 2004-03-04 PT PT04717398T patent/PT1601670E/pt unknown
- 2004-03-04 DK DK09075124.9T patent/DK2085395T3/da active
- 2004-03-04 EA EA200501425A patent/EA010870B1/ru active IP Right Revival
- 2004-03-04 DE DE602004031165T patent/DE602004031165D1/de not_active Expired - Lifetime
- 2004-03-04 AT AT09075124T patent/ATE496046T1/de active
- 2004-03-04 ES ES04717398T patent/ES2309507T3/es not_active Expired - Lifetime
- 2004-03-04 WO PCT/US2004/006530 patent/WO2004078752A1/en not_active Ceased
- 2004-03-08 CL CL200400452A patent/CL2004000452A1/es unknown
2005
- 2005-08-08 IL IL170155A patent/IL170155A/en active IP Right Grant
- 2005-08-17 US US11/206,243 patent/US20060094732A1/en not_active Abandoned
- 2005-08-24 ZA ZA200506790A patent/ZA200506790B/xx unknown
- 2005-09-05 NO NO20054120A patent/NO331920B1/no not_active IP Right Cessation
2008
- 2008-08-06 CY CY20081100831T patent/CY1110391T1/el unknown
- 2008-08-07 US US12/187,584 patent/US7714001B2/en not_active Expired - Lifetime
- 2008-12-17 AU AU2008258188A patent/AU2008258188B2/en not_active Ceased
- 2008-12-17 AU AU2008258187A patent/AU2008258187B2/en not_active Ceased
2009
- 2009-01-05 US US12/348,605 patent/US8063068B2/en not_active Expired - Lifetime
- 2009-02-05 AR ARP090100389A patent/AR070570A2/es not_active Application Discontinuation
- 2009-02-05 AR ARP090100388A patent/AR070569A2/es not_active Application Discontinuation
- 2009-04-05 IL IL197889A patent/IL197889A/en active IP Right Grant
- 2009-04-05 IL IL197890A patent/IL197890A/en active IP Right Grant
- 2009-05-14 NO NO20091888A patent/NO332293B1/no not_active IP Right Cessation
- 2009-06-09 NO NO20092231A patent/NO20092231L/no unknown
- 2009-07-31 JP JP2009178896A patent/JP5537084B2/ja not_active Expired - Lifetime
- 2009-07-31 JP JP2009178897A patent/JP5537085B2/ja not_active Expired - Lifetime
2010
- 2010-01-06 US US12/683,106 patent/US8067443B2/en not_active Expired - Fee Related
2011
- 2011-02-24 US US13/033,719 patent/US8633222B2/en not_active Expired - Fee Related
- 2011-04-05 CY CY20111100351T patent/CY1111615T1/el unknown
2013
- 2013-12-17 US US14/108,918 patent/US20140107164A1/en not_active Abandoned
2015
- 2015-02-24 US US14/629,517 patent/US20150164894A1/en not_active Abandoned

Also Published As

Publication number	Publication date
NO20091888L (no)	2005-10-03
JP5537084B2 (ja)	2014-07-02
EP2085395B1 (de)	2011-01-19
AU2004217903B2 (en)	2010-03-04
ATE394394T1 (de)	2008-05-15
BRPI0409576A (pt)	2006-04-18
US7098331B2 (en)	2006-08-29
SI1601670T1 (sl)	2008-10-31
PL394600A1 (pl)	2011-07-18
HK1084949A1 (en)	2006-08-11
NO331920B1 (no)	2012-04-30
AU2008258188B2 (en)	2011-02-24
EA014714B1 (ru)	2011-02-28
PL378415A1 (pl)	2006-04-03
MXPA05009386A (es)	2005-11-04
HK1130254A1 (en)	2009-12-24
US20040176348A1 (en)	2004-09-09
PL215059B1 (pl)	2013-10-31
US8067443B2 (en)	2011-11-29
DE602004031165D1 (de)	2011-03-03
US20110152293A1 (en)	2011-06-23
CL2004000452A1 (es)	2005-05-20
EP1601670B1 (de)	2008-05-07
JP2009292825A (ja)	2009-12-17
ES2389106T3 (es)	2012-10-23
PA8597201A1 (es)	2004-09-28
IL197890A (en)	2013-11-28
ES2309507T3 (es)	2008-12-16
KR20060006006A (ko)	2006-01-18
EA010870B1 (ru)	2008-12-30
KR100953150B1 (ko)	2010-04-19
ZA200506790B (en)	2006-05-31
CN101550132A (zh)	2009-10-07
NO332293B1 (no)	2012-08-20
EA200501425A1 (ru)	2006-02-24
PT2085395E (pt)	2011-04-20
US8063068B2 (en)	2011-11-22
DK2085395T3 (da)	2011-04-18
US20080293778A1 (en)	2008-11-27
DK1601670T3 (da)	2008-08-25
CN1756754A (zh)	2006-04-05
AU2004217903A1 (en)	2004-09-16
PE20040930A1 (es)	2005-02-18
CA2516514C (en)	2012-02-07
AU2008258188A1 (en)	2009-01-15
PT1601670E (pt)	2008-07-11
AR043469A1 (es)	2005-07-27
KR20090021228A (ko)	2009-02-27
TW200927745A (en)	2009-07-01
CY1110391T1 (el)	2015-04-29
PL216979B1 (pl)	2014-06-30
IL197889A (en)	2013-03-24
TW200505909A (en)	2005-02-16
EA200801764A1 (ru)	2008-12-30
NO20054120L (no)	2005-10-03
JP2006519868A (ja)	2006-08-31
PL2085395T3 (pl)	2011-05-31
US7714001B2 (en)	2010-05-11
EP1601670A1 (de)	2005-12-07
WO2004078752A1 (en)	2004-09-16
NZ541795A (en)	2008-03-28
UY28218A1 (es)	2005-06-30
NO20054120D0 (no)	2005-09-05
JP4663627B2 (ja)	2011-04-06
SI2085395T1 (sl)	2011-05-31
EP2085395A1 (de)	2009-08-05
AU2008258187B2 (en)	2010-08-05
US20100267776A1 (en)	2010-10-21
CY1111615T1 (el)	2015-10-07
DE602004013553D1 (de)	2008-06-19
EA200900706A1 (ru)	2009-10-30
AR070570A2 (es)	2010-04-21
PL394604A1 (pl)	2011-07-18
CN101550132B (zh)	2012-03-28
CA2516514A1 (en)	2004-09-16
PL1601670T3 (pl)	2008-10-31
KR101018083B1 (ko)	2011-03-02
US20100010042A1 (en)	2010-01-14
US20060094732A1 (en)	2006-05-04
US20150164894A1 (en)	2015-06-18
KR101185541B1 (ko)	2012-09-24
US20140107164A1 (en)	2014-04-17
ATE517893T1 (de)	2011-08-15
IL170155A (en)	2013-08-29
TWI377204B (en)	2012-11-21
CN101255155A (zh)	2008-09-03
NO20092231L (no)	2005-10-03
US8633222B2 (en)	2014-01-21
TW200927746A (en)	2009-07-01
KR20090021227A (ko)	2009-02-27
AU2008258187A1 (en)	2009-01-15
HK1116800A1 (en)	2009-01-02
JP2010001296A (ja)	2010-01-07
JO2488B1 (en)	2009-10-05
EP1947100A1 (de)	2008-07-23
CN100526308C (zh)	2009-08-12
KR20120014236A (ko)	2012-02-16
ES2385941T3 (es)	2012-08-03
TWI339662B (en)	2011-04-01
GT200400033A (es)	2005-05-29
EA019240B1 (ru)	2014-02-28
JP5537085B2 (ja)	2014-07-02
AR070569A2 (es)	2010-04-21
EP1947100B1 (de)	2011-07-27

Legal Events

Date

Code

Title

Description

2011-08-15

UEP

Publication of translation of european patent specification

Ref document number: 2085395

Country of ref document: EP

Publication	Publication Date	Title
DE602004031723D1 (de)	2011-04-21	Mikrofasern enthaltende polyester und verfahren zu deren herstellung und verwendung
ATE556077T1 (de)	2012-05-15	Tetrahydrochinolinderivate und verfahren zu deren herstellung
DE60333438D1 (de)	2010-09-02	Beschichtete gefässprothesen, verfahren zu deren herstellung und verwendung derselben
EP1743174A4 (de)	2008-08-20	Multimodale nanostrukturen, verfahren zu deren herstellung und verwendung
DE602006012666D1 (de)	2010-04-15	Ren eignen und verfahren zu deren herstellung
DE60332953D1 (de)	2010-07-22	Gleichmässiges faservlies und verfahren zu dessen herstellung
DE602005020467D1 (de)	2010-05-20	Dielektrische luneberglinse und verfahren zu ihrer herstellung
DE50310782D1 (de)	2008-12-24	Piezoaktor und verfahren zu dessen herstellung
ATE346065T1 (de)	2006-12-15	Substituierte thiazol- benzoisothiazoldioxidderivative, verfahren zu deren herstellung und deren verwendung
DE60334183D1 (de)	2010-10-28	Faserplatte und Verfahren zu ihrer Herstellung
DE602004008991D1 (de)	2007-10-31	Umlenkbeschlag und verfahren zu dessen herstellung
ATE482193T1 (de)	2010-10-15	Indolonacetamidderivate, verfahren zu deren herstellung und deren verwendungen
DE60332463D1 (de)	2010-06-17	Hochbrillianter mechanolumineszenzstoff und verfahren zu seiner herstellung
DE602004031165D1 (de)	2011-03-03	Arylvinylazacycloalkan-Verbindungen und Verfahren zu deren Herstellung und Verwendung
ATE433453T1 (de)	2009-06-15	Kondensierte pyrrolocarbazole und verfahren zu deren herstellung
DE50214272D1 (de)	2010-04-22	Piezoelektrisches bauelement und verfahren zu dessen herstellung
DE502004005578D1 (de)	2008-01-03	Hochtackige klebmasse, verfahren zu deren herstellung und deren verwendung
DE60235706D1 (de)	2010-04-29	Photochrome bis-naphtopyranverbindungen und verfahren zu deren herstellung
DE60304694D1 (de)	2006-05-24	Flügeloberfläche und verfahren zu deren herstellung
DE50311585D1 (de)	2009-07-23	Fahrzeugtür und verfahren zu deren herstellung
DE60323689D1 (de)	2008-10-30	Schräg geschichtetes furniermaterial und verfahren zu dessen herstellung
DE602004028584D1 (de)	2010-09-23	Emulsionsförmiger haftklebstoff und verfahren zu seiner herstellung
DE602004031350D1 (de)	2011-03-24	Penamkristall und verfahren zu dessen herstellung
DE502004010268D1 (de)	2009-12-03	Bitleitungsstruktur sowie verfahren zu deren herstellung
ATA3752003A (de)	2004-04-15	Verbundwerkstoff und verfahren zu dessen herstellung